COVID-19 Response
BTS Research is taking in animals for temporary housing from local vivariums BTS provides services in the following research animals: Rodents. Rabbits. Guinea pigs. Dogs NHP's. Contact us for more details.
MHRA Temporarily Eases Some GMP Requirements
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) is relaxing some GMP requirements to help manufacturers overcome challenges during the COVID-19 pandemic. Source: Devices & Diagnostics Letter
Remdesivir Trial Data Leak Shows No Benefits in COVID-19 Patients
Results from a Chinese trial of Gilead’s antiviral remdesivir show no benefit in COVID-19 patients, according to data accidentally posted on the World Health Organization’s (WHO) website. Source: Devices &…
FDA Eases Requirements for Repackaging of Propofol
In an emergency final guidance released yesterday, the FDA agency said it is temporarily relaxing its regulations for repackaging and combining units of propofol during the COVID-19 pandemic. Source: Devices…
J&J Partners With Emergent to Produce COVID-19 Vaccine
Johnson & Johnson is partnering with Emergent Biosolutions to scale up manufacturing of a COVID-19 vaccine. Source: Devices & Diagnostics Letter
New York Files Opioid Fraud Charges Against Mallinckrodt
The state of New York has filed civil charges against Mallinckrodt for its alleged role in the opioid epidemic. Source: Drug Industry Daily
Insmed’s Brensocatib Enters Trial as Possible COVID-19 Treatment
Insmed is sponsoring a clinical trial in the UK of its bronchial drug Brensocatib as a potential COVID-19 treatment. Source: Drug Industry Daily
Valneva and Dynavax Collaborate to Develop COVID-19 Vaccine
Dynavax used the adjuvant in its FDA-approved hepatitis B vaccine. Source: Devices & Diagnostics Letter
FDA Approves Sanofi’s Meningococcal Vaccine
MenQuadfi will be available in a ready-to-use liquid formulation to allow healthcare providers to avoid vaccine reconstitution. Source: Devices & Diagnostics Letter
FDA Approves Immunomedic’s Breast Cancer Treatment Trodelvy
The FDA previously granted the drug priority review, breakthrough therapy and fast- track designations. Source: Devices & Diagnostics Letter